St. Denis et al., “Fragment-based drug discovery: opportunities for organic synthesis”; RSC Medicinal Chemistry, 2021

St. Denis et al., “Fragment-based drug discovery: opportunities for organic synthesis”; RSC Medicinal Chemistry, 2021

https://pubs.rsc.org/en/content/articlelanding/2021/md/d0md00375a#!divAbstract

Jahnke et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2019”; Journal of Medicinal Chemistry, 2020

Jahnke et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2019”; Journal of Medicinal Chemistry, 2020

https://doi.org/10.1021/acs.jmedchem.0c01608

Cadilla et al., “The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure”; Bioorganic & Medicinal Chemistry, 2020

Cadilla et al., “The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure”; Bioorganic & Medicinal Chemistry, 2020

https://doi.org/10.1016/j.bmc.2020.115791

Downes et al., “Design and Synthesis of 56 Shape-Diverse 3D Fragments”; Chemistry: A European Journal, 2020

Downes et al., “Design and Synthesis of 56 Shape-Diverse 3D Fragments”; Chemistry: A European Journal, 2020

https://chemistry-europe.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/chem.202001123

Erlanson et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2018”; Journal of Medicinal Chemistry, 2020

Erlanson et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2018”; Journal of Medicinal Chemistry, 2020

https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01581

Coyle et al., “Applied Biophysical Methods in Fragment-Based Drug Discovery”; SLAS DISCOVERY, 2020

Coyle et al., “Applied Biophysical Methods in Fragment-Based Drug Discovery”; SLAS DISCOVERY, 2020

https://journals.sagepub.com/doi/full/10.1177/2472555220916168?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Saur et al. “Fragment-based drug discovery using cryo-EM”, Drug Discovery Today, 2020

Saur et al. “Fragment-based drug discovery using cryo-EM“, Drug Discovery Today, 2020
https://www.sciencedirect.com/science/article/pii/S1359644619304659?viewFullText=true

Osbourne et al., “Fragments: where are we now?”; Biochemical Society Transactions, 2020

Osbourne et al., “Fragments: where are we now?”; Biochemical Society Transactions, 2020
https://portlandpress.com/biochemsoctrans/article-abstract/48/1/271/221949/Fragments-where-are-we-now?redirectedFrom=fulltext

Rathi et al., “Practical High-Quality Electrostatic Potential Surfaces for Drug Discovery Using a Graph-Convolutional Deep Neural Network”; Journal of Medicinal Chemistry, 2020

Rathi et al., “Practical High-Quality Electrostatic Potential Surfaces for Drug Discovery Using a Graph-Convolutional Deep Neural Network”, Journal of Medicinal Chemistry, 2020; https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01129

Kidger et al. “Dual-mechanism ERK1/2 inhibitors exploit a distinct binding mode to block phosphorylation and nuclear accumulation of ERK1/2”, Molecular Cancer Therapeutics, 2019

Kidger et al., “Dual-mechanism ERK1/2 inhibitors exploit a distinct binding mode to block phosphorylation and nuclear accumulation of ERK1/2“, Molecular Cancer Therapeutics, 2019
https://mct.aacrjournals.org/content/early/2019/11/20/1535-7163.MCT-19-0505